Influence of serological factors and BMI on the blood pressure/hematocrit association in healthy young men and women. by Salazar Vázquez, Beatriz Y et al.
UC San Diego
UC San Diego Previously Published Works
Title
Influence of serological factors and BMI on the blood pressure/hematocrit association in 




Salazar Vázquez, Beatriz Y









eScholarship.org Powered by the California Digital Library
University of California
© 2014 Salazar Vázquez et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) 
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Vascular Health and Risk Management 2014:10 271–277
Vascular Health and Risk Management Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
271
O R i g i n a l  R e s e a R c H
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/VHRM.S60130
Influence of serological factors and BMI  
on the blood pressure/hematocrit association  
in healthy young men and women
Beatriz Y Salazar Vázquez1,2,5







1Faculty of Medicine, Universidad 
Juárez del Estado de Durango, 
Victoria de Durango, Dgo, Mexico; 
2Department of Experimental 
Medicine, Faculty of Medicine, 
Universidad Nacional Autónoma de 
México, Hospital general de México 
Dr Eduardo Liceaga, México City, 
Mexico; 3Department of Pediatrics, 
Hospital general de Zona no. 1, 
instituto Mexicano del seguro social, 
Durango, Dgo, Mexico; 4Hospital de 
especialidades, instituto Mexicano 
de Seguro Social, México DF, Mexico; 
5Department of Bioengineering, 
University of California, San Diego, 
CA, USA
Correspondence: Beatriz Y Salazar 
Vázquez 
Department of Bioengineering, University 
of California, San Diego, 9500 Gilman 
Drive, La Jolla, CA 92093-0412, USA 
Tel +1 858 534 4275 
email bsalazarvazquez@gmail.com
Abstract: The association between mean arterial blood pressure (MAP) and hematocrit (Hct) 
as a surrogate for blood viscosity was investigated in a young (average 20.0±2.3 years), healthy 
population of 174 men and 442 women. Health status was assessed by clinical examination and 
serological evaluation. Individuals with severe anemia or hemoconcentration, prior traumas or 
major surgical intervention, smokers, and pregnant or lactating women were excluded from 
the study. The MAP/Hct association was positive and significant (P=0.04) for women and 
negative, albeit not significantly so, for men. The MAP/Hct association was also evaluated in 
subgroups of the same population with a progressive step-by-step exclusion of: individuals 
with cholesterol .200 mg/dL; triglycerides .200 mg/dL; body mass index .25 kg/m2; and 
glucose .100 mg/dL. This consecutively reduced the strength of the positive MAP/Hct associa-
tion in women, which became negative – although not significantly so – when all anomalously 
high factors were excluded. The same trend was found in men. Our study indicates that previ-
ously reported positive trends in the relationship between the MAP and Hct in the population 
are not present in a young, healthy population of men or women that excludes individuals with 
the confounding factors of above normal serological values and BMI.
Keywords: blood pressure, blood viscosity, hematocrit, vascular resistance, endothelial 
dysfunction
Introduction
A direct relationship between hypertension, elevated hematocrit (Hct), and blood vis-
cosity was found in studies pioneered by Letcher et al.1 These results were confirmed 
by findings of the Edinburgh Artery Study, a study that evaluated the blood pressure/
viscosity association in 1,592 men and women aged 55–74 years.2 This study concluded 
that there was evidence of a strong association between blood viscosity and arterial 
pressure, independently of confounding factors. The same conclusion was reached by 
the Gubbio Population Study (2,809 men and women aged 25–74 years).3 That study 
reported a significant independent association between Hct and the prevalence of 
hypertension and a positive relationship between Hct and blood pressure.
Studies conducted in a population4 of .100,000 blood donors in the Netherlands 
reported a positive association between hemoglobin levels and systolic and diastolic blood 
pressure in adult men and women (49.3±12.5 and 42.4±13.7 years). This study included 
individuals considered to be healthy with data adjusted for age, body mass index (BMI), 
mean daily temperature, season, smoking, and antihypertensive drug treatment.
However, studies in populations that can be clinically evaluated tend to show that a 
significant positive association between MAP and Hct is related to age and/or clinical 
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conditions that may coexist with endothelial dysfunction.5–7 
Conversely, healthy controls in these studies tend not to show 
a positive correlation between MAP and Hct.
Normal endothelial function regulates peripheral vascular 
resistance due to changes in blood viscosity, by producing 
the vasodilators nitric oxide and prostacyclin via mechan-
otransduction in response to flow-induced shear stress on the 
vascular wall.8 Shear stress at the vessel wall due to blood 
viscosity, flow, and blood vessel diameter therefore contrib-
utes to the autoregulation of blood pressure if the endothelium 
is responsive and – presumably – healthy.9
In a previous study, we investigated the relationship 
between MAP and Hct in a healthy population residing in the 
same locality;10 however, factors that may influence the MAP/
Hct trend were not explored. In the present study, we inves-
tigated the relationship of MAP versus Hct in a relatively 
uniform population of younger adults whose health status 
was determined by clinical interview and anthropometric and 
serological measurements, with the aim of finding readily 
measurable variables that affect the MAP/Hct trend.
Methods
The study was carried out in an open population of young adults 
aged 17–25 years in the city of Durango, Mexico, invited to par-
ticipate by means of radio and newspaper announcements made 
by the Universidad Juárez del Estado de Durango. The study 
was approved by the Ethical Committee of the Universidad 
Nacional Autónoma de México, México DF, Mexico. Written 
informed consent was obtained and signed by all participants 
prior to the investigation. Parents or guardians provided the 
written consent for minors (individuals under 18 years).
Both females and males who were considered healthy 
blood donors as determined by the analysis of a written 
questionnaire, blood pressure measurement not showing 
hypertension, and the absence of the exclusion criteria, were 
all included in the study. Individuals were excluded from the 
study with diagnosis of hemorheological perturbations, such 
as: severe anemia (blood hemoglobin ,10 and 12 g/dL for 
women and men respectively); hemoconcentration (hemo-
globin .18 and 20 g/dL for women and men respectively); 
traumas or major surgical intervention in the preceding 
six months; and smoking habits (those who in the previous 
6 months consumed at least one cigarette). We additionally 
excluded subjects with previous or recent diagnosis of dia-
betes mellitus, cardiovascular diseases, chronic hepatic or 
renal disease, inflammatory or autoimmune disorders, acute 
or chronic infectious diseases, cancer, endocrine disorders, 
as well as pregnant or lactating women.
All participants were asked to provide their clinical  history. 
Height, weight, BMI, and blood pressure (criteria of the VII 
Joint National Committee on Prevention, Detection, and 
Treatment; High Blood Pressure, National Heart, Lung, and 
Blood Institute; 2003) were measured at this time.
Hematocrit varies through the day as a function of fluid and 
food intake, level of exercise, etc. Therefore, to ensure a degree 
of uniformity of hydration, participants were summoned at 8 am 
for blood sampling, after 8–12 hours of fasting. Blood pres-
sure was measured first after 5 minutes of resting in the sitting 
position with an automatic instrument (Omron model BP742, 
Omron Healthcare, Inc., Bannockburn, IL, USA) three times in 
the left arm at heart level, at 5-minute intervals and averaged. 
Glucose, cholesterol, and triglycerides were measured in drawn 
blood samples with the instrument Accutrend® GCT (Roche 
Diagnostics GmbH, Mannheim, Germany), which uses a drop 
of blood obtained from an index finger puncture. Hematocrit 
and hemoglobin determinations were made by the same method 
using the instrument HemoCue Hb 201 (HemoCue, Inc., 
Cypress, CA, USA). These tests were subsequently repeated 
for individuals who had significant clinical alterations, using 
standard laboratory analysis techniques.
statistical analysis
The association between MAP and Hct for the population was 
evaluated by determining the Spearman’s correlation coef-
ficient of these two variables. The influence of serological 
factors and BMI upon the MAP/Hct relationship was assessed 
by the consecutive step-by-step removal of individuals who 
had values above the normal thresholds for these parameters 
and reanalyzing the level of association by means of the 
Spearman’s correlation coefficient, excluding individuals 
according to the backward-stepwise selection method.11
The order of removal was established by ranking the sero-
logical parameters and the BMI above the normal threshold 
that caused the steepest slope on the MAP/Hct association (ie, 
produced the strongest effect) when only the individuals with 
this parameter anomaly were investigated. Individuals with 
the parameter showing the strongest effect were removed first. 
Statistical analysis was performed using the GraphPad Prism 
5 software (GraphPad Software, Inc., La Jolla, CA, USA). 
Differences were considered significant when P,0.05.
Results
The study included 616 individuals (442 women and 174 men), 
aged 17–25 years. The average age was 20.0±2.3 years. The 
principal characteristics of the population studied are given 
in Table 1.
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Table 1 Demographic, anthropometric, and serologic 
characteristics of the young adult population examined in the 
municipality of the city of Durango, Mexico
Sex Men =174 Women =442
age, years 20.4±2.5 19.7±2.2
Weight, kg 75.8±15.3 60.1±11.8
Height, m 1.74±0.07 1.60±0.06
BMI, kg/m2 24.8±4.3 23.4±4.1
Mean arterial pressure, mmHg 91.2±7.4 85.0±8.3
Cardiac frequency, beats/minute 67.2±11.5 71.0±11.7
Waist-to-hip ratio 0.94±0.06 0.89±0.06














Notes: all demographic and anthropometric parameters, including Hct, are 
significantly different (P,0.002). Serological parameters (*) are not significantly 
different. 
































Figure 1 MAP plotted as function of Hct for the study population of individuals described in Table 1.
Notes: The association MAP/Hct is positive and significant (P=0.04, r=0.10) for women (n=442) and negative but not significant (r=−0.05) for men (n=174). This association 
becomes negative but not significant for women when individuals with serological and BMI values exceeding normal values are excluded. The same exclusion applied to men 
causes the association to become more negative without reaching significance.
Abbreviations: MAP, mean arterial blood pressure; Hct, hematocrit; BMI, body mass index; n, number.
normal serological and BMI thresholds. The differences 
between and men and women in BMI, MAP, glucose, cho-
lesterol, and triglycerides are typical of the Mexican popula-
tion; these same trends have been previously reported.12 The 
difference in Hct between men and women is found in all 
healthy young populations.13
The slope of the MAP/Hct association was evaluated for 
groups whose individuals had each of their serological and 
BMI values above the normalcy threshold. This analysis 
showed that the steepest slope for the MAP/Hct relationship 
occurred in individuals with cholesterol levels .200 mg/dL; 
progressively lesser effects were observed in the order of 
parameters shown in Table 2.
This information was used to reevaluate the MAP/Hct 
relationship in groups in which individuals with values 
above the threshold for a given parameter were progressively 
removed from the respective group, in the order shown in 
Table 2, obtaining the results shown in Tables 3 and 4.
The net effect of this treatment of the data was the non-
significant lowering of the value of m (slope) (Tables 3 and 4) 
in the association between MAP and Hct. Excluding women 
with abnormally high cholesterol caused their positive MAP/
Hct association to become not statistically significant, chang-
ing the P-value from 0.04–0.14. The subsequent exclusion of 
women with high triglycerides yielded P=0.90 for the MAP/
Hct association. Further step -by-step removal of individuals 
with above threshold values of BMI and glucose caused the 
trend to become negative (but not significant). Applying the 
procedure to the data from men caused the negative slope of 
The relationship between MAP and Hct was evaluated 
for the whole study population separated by sex. Results are 
presented in Figure 1 showing that the trend of MAP/Hct 
association is positive and significant for women (P=0.04; 
r=0.10), and negative – albeit not significant – for men 
(P=0.91; r=−0.05).
As shown in Table 1, men and women presented vari-
ability in parameter values. Some individuals exceeded the 
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Table 2 Thresholds defining the upper limit of parameters for 
the normal population
Thresholds Average and STD of % exceeding threshold
Men Women
cholesterol
 200 mg/dl 223.4±22.8; 4.0% 219.3±20.4; 4.1%
Triglycerides
 200 mg/dl 300.2±109.5; 21.3% 297.9±108.6; 15.4%
BMI
 25 kg/m2 27.9±3.2; 46.6% 28.5±3.5; 28.7%
glucose
 100 mg/dl 113.7±15.0; 39.1% 110.0±10.0; 36.0%
Abbreviations: STD, standard deviation; BMI, body mass index.
Table 3 Women
n m, mmHg/Hct P r
all women 442 0.285±0.140 0.04 0.10
all minus chol .200 mg/dl 424 0.214±0.145 ns 0.07
all minus chol, trig .200 mg/dl 363 0.020±0.156 ns 0.00
all minus chol, trig,  
BMI .25 kg/m2
266 −0.022±0.178 ns 0.00
All minus chol, trig, BMI,  
glu .100 mg/dl
166 −0.032±0.213 ns −0.01
Notes: Statistical characteristics of the association MAP versus Hct as a function of 
threshold of chol, trig, BMI, and glu.
Abbreviations: MAP, mean arterial blood pressure; m, slope; Hct, hematocrit; 
chol, cholesterol; trig, triglycerides; BMI, body mass index; glu, glucose; 
ns, nonsignificant association; n, number.
Table 4 Men
n m (slope) P r
all men 174 −0.020±0.179 ns −0.05
all minus chol .200 mg/dl 167 −0.024±0.185 ns −0.01
all minus chol, trig .200 mg/dl 134 −0.035±0.206 ns −0.02
all minus chol, trig,  
BMI .25 kg/m2
77 −0.019±0.260 ns −0.00
All minus chol, trig, BMI,  
glu .100 mg/dl
39 −0.193±0.368 ns −0.09
Notes: Statistical characteristics of the association MAP versus Hct as a function 
threshold of chol, trig, BMI, and glu.
Abbreviations: m, slope; Hct, hematocrit; chol, cholesterol; trig, triglycerides; 
BMI, body mass index; glu, glucose; ns, nonsignificant association; n, number.
the MAP/Hct association to become progressively steeper, 
ie, with a numerically greater negative slope m, although 
without reaching significance.
Discussion
The principal result of this study is that – in a young 
healthy population, with normal serological parameters 
and BMI – the relationship between MAP and Hct for 
men and women shows a nonsignificant negative trend. 
This result is different from that found in several studies of 
older populations showing positive and significant trends.2,3 
We also show that excluding healthy women who present 
serological parameters beyond the threshold of normalcy 
reduces the strength (ie, the slope and the significance) of 
the association between MAP and Hct, which becomes 
negative although not significant when the confounding 
factors are removed.
In the case of men, the MAP/Hct association is negative 
but not significant for the whole population; removing indi-
viduals with anomalous parameter values reduces the slope 
and the strength of the association. However, this reduction 
is not significant.
The path taken to investigate the effect of above threshold 
serological parameters and BMI on the MAP/Hct associa-
tion is somewhat arbitrary since it does not account for the 
incidence of occurrence (ie, proportion of individuals) of 
the abnormalities in the population. The significant result 
is that there is no MAP/Hct association in a population that 
has normal serological data and BMI, and that – in the tested 
population – only 9% of women and 22% of men could be 
considered normal, according to the chosen criteria.
The proportion of males with no BMI or serology abnor-
malities was 28.7% versus 38.7% for women, a difference 
due to the incidence of overweight and obesity in men 
(46.6% versus 28.5%).
Blood viscosity is primarily determined by Hct, being 
a nonlinear function of this parameter.13,14 However, the 
relationship between blood viscosity and Hct for the nor-
mal range of variability of Hct in the population can be 
considered linear,10 which facilitates the study of the MAP/
blood viscosity relationship in large populations, where the 
measurement of blood viscosity could be substituted with 
the measurement of Hct.
In our study, we used Hct as a surrogate for blood viscos-
ity, an assumption that may not be accurate in older individu-
als who may show altered plasma composition, particularly 
concerning fibrinogen and other rheological abnormalities, 
such as decreased red blood cell flexibility.15 Although we 
did not evaluate blood fibrinogen, this assumption should 
be accurate for the population studied, given its age and 
health.16
Blood viscosity is one of the determinants of peripheral 
vascular resistance17 and, hence, in a circulatory system 
consisting of rigid tubes increasing blood viscosity increases 
vascular resistance, according to the Hagen–Poiseuille law. 
Supporting experimental data on the effect of blood viscosity 
on MAP originate with the classical studies of Richardson 
and Guyton18 and those of Messmer et al.19 However, the Hct 
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changes studied were significantly greater than those associ-
ated with the variability of Hct in the normal population.
Experimental studies on changes of Hct in the range of 
variability of the normal population yield different results. 
Martini et al20,21 showed in awake animals that acutely increas-
ing blood viscosity above normal by about 10% through 
altering isovolemic hemoconcentration significantly lowered 
the MAP and increased the cardiac output. It should be noted 
that these are acute responses that may not extrapolate to 
chronic conditions. However, these changes of blood pres-
sure lasting several hours do not appear to be regulated by 
baroreceptor responses.
The control of peripheral vascular resistance in the nor-
mal organism independently from the activity of the central 
nervous system is linked to mechanotransduction, via shear 
stress at the blood vessel wall that governs the production 
of vasodilators.22,23 Shear stress is in part determined by 
blood viscosity,24,25 which can have two opposing effects on 
peripheral vascular resistance. Namely, it can have a direct 
effect due to simple hemodynamic hindrance and a second, 
opposite effect due to the response to vasodilator release.
Evidence for lack of association between 
MaP and blood viscosity
Our results support the concept that increased Hct does not 
lead to an increased MAP in the young, healthy population. 
Furthermore, our present and previous studies indicate that 
the association may be negative, with increased Hct leading 
to lower MAP. Therefore, it is of interest to briefly analyze 
the results of previous studies in terms of the characteristics 
of the populations tested.
The relationship between blood viscosity and MAP was 
studied in a healthy population of 84 men and 65 women 
(30.6±8.0 years) from the city of Durango. The trend of asso-
ciation with MAP/viscosity was negative but not significant 
for women; there was a negative linear correlation (r=0.22; 
P=0.03) for men.10
The study of de Simone et al26 showed that systolic blood 
pressure and blood viscosity were negatively correlated in 
the Native Americans who participated in the Strong Heart 
Study (P,0.01).26 Conversely, Paul et al27 showed that hyper-
tension and anemia, and therefore decreased blood viscosity, 
were positively correlated. A group of 646 young male office 
workers (age range, 18–41 years; 28.3±5.6) in Tokyo, Japan, 
was investigated using multiple regression analysis of systolic 
(SBP) and diastolic blood pressure (DBP) using Hct, age, BMI, 
and drinking and smoking habits as independent variables. 
The results showed that Hct was a significant independent 
variable for DBP (P,0.001) but not for SBP.28 This association 
can be interpreted to be representative of a normal endothelial 
autoregulation of peripheral vascular resistance.29
A study of healthy subjects selected from participants in 
a campaign of prevention of cardiovascular disease (n=103) 
in Catanzaro, Italy, showed that the only variables that were 
significantly positively associated were SBP and age, and 
DBP and Hct.30
The effect of aging on endothelial function is evident 
in women that pass from pre- to postmenopause.31 Salazar 
Vázquez et al32 analyzed the distribution of MAP and Hct 
in a population of pre- and postmenopause women from the 
city of Durango, Mexico. In this study, healthy nonsmok-
ing premenopausal women (n=85) showed a nonsignificant 
negative correlation (P=0.5) between MAP and Hct, while 
menopausal women (n=92) presented a positive correlation 
(P,0.01). Women aged .60 years in the city of Stockholm, 
Sweden, (n=2,189) showed an identical MAP/Hct trend to 
that of menopausal women in Durango.32
The study of de Simone et al33 found a significant 
independent relation between SBP, DBP, MAP, and blood 
viscosity (measured over a range of shear rates) as well as 
Hct (r=0.17–0.23; all P,0.05) in a cohort of normotensive 
members of the employed population in New York City.34 
The study included apparently normal men and women who 
were 27–75 years old.
Adaptation to altitude increases Hct and MAP35, the 
increase in MAP preceding the increase in Hct; however, 
the prolonged residence at high altitude lowers MAP rela-
tive to that of sea level residents.36–38 The decrease of MAP 
with altitude is attributed to the relaxation of the vascular 
smooth muscle, increased collateral circulation, increased 
vascularization,39 higher red blood cell and hemoglobin lev-
els, hypocaloric stress, and respiratory ailments.40,41
However, the hypothesis that this may be due to increased 
mechanotransduction caused by increased Hct and blood 
viscosity appears to have not been considered. In general, 
children and young adults of populations that adapt to alti-
tude by increasing Hct have comparatively lower MAP than 
similarly aged populations at sea level.
A common trend in these studies is that the MAP/Hct 
association is positive in conditions where the organism has 
some form of dysfunction; it is not significant in healthy 
persons.
Conclusion
Our results show that, in normal healthy males and females, 
MAP is not elevated when Hct is higher than the norm if 
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the serological parameters and the BMI do not exceed the 
normalcy thresholds. Most studies in the literature that 
report a positive and significant association between MAP 
and Hct include older individuals. Values of plasma glucose, 
cholesterol, and triglycerides exceeding the normal thresh-
old are related to increased blood pressure. Hence, it is not 
surprising that the exclusion of these individuals lowers the 
strength of the MAP/Hct association. A mechanism that may 
in part explain the lack of MAP/Hct association for normal 
individuals is the increase of shear stress at the blood vessel 
wall interface due to increased viscosity, which – according 
to the mechanisms of endothelial biochemical mechanotrans-
duction – increases the release of vasodilators by the endothe-
lium, an effect not present with endothelial dysfunction.8
Our results indicate that the increase in Hct in healthy 
young individuals is not related to the increase of MAP.
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